|
|
Volumn 30, Issue 1, 2004, Pages 131-137
|
|
High-dose chemotherapy and stem cell transplantation does not improve relapse-free or overall survival in women with high-risk breast cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CANCER STAGING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
DOSE RESPONSE;
FEMALE;
HUMAN;
LYMPH NODE;
MASTECTOMY;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEEDLE BIOPSY;
PATHOLOGY;
PROBABILITY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REFERENCE VALUE;
RISK ASSESSMENT;
STEM CELL TRANSPLANTATION;
SURVIVAL;
TREATMENT OUTCOME;
UNITED STATES;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
LYMPH NODES;
MASTECTOMY;
MIDDLE AGED;
NEOPLASM STAGING;
PROBABILITY;
PROGNOSIS;
REFERENCE VALUES;
RISK ASSESSMENT;
STEM CELL TRANSPLANTATION;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 1442332941
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ctrv.2003.11.007 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
